- Home
- AVNW vs RCKT Comparison
AVNW vs RCKT Comparison
Compare AVNW & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVNW
- RCKT
- Stock Information
- Founded
- AVNW 2006
- RCKT 1999
- Country
- AVNW United States
- RCKT United States
- Employees
- AVNW N/A
- RCKT N/A
- Industry
- AVNW Radio And Television Broadcasting And Communications Equipment
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- AVNW Technology
- RCKT Health Care
- Exchange
- AVNW Nasdaq
- RCKT Nasdaq
- Market Cap
- AVNW 274.4M
- RCKT 328.6M
- IPO Year
- AVNW 2007
- RCKT N/A
- Fundamental
- Price
- AVNW $24.38
- RCKT $3.97
- Analyst Decision
- AVNW Strong Buy
- RCKT Buy
- Analyst Count
- AVNW 3
- RCKT 13
- Target Price
- AVNW $32.00
- RCKT $12.88
- AVG Volume (30 Days)
- AVNW 76.9K
- RCKT 3.1M
- Earning Date
- AVNW 11-04-2025
- RCKT 11-03-2025
- Dividend Yield
- AVNW N/A
- RCKT N/A
- EPS Growth
- AVNW N/A
- RCKT N/A
- EPS
- AVNW 0.10
- RCKT N/A
- Revenue
- AVNW $434,606,000.00
- RCKT N/A
- Revenue This Year
- AVNW $5.75
- RCKT N/A
- Revenue Next Year
- AVNW $6.82
- RCKT $3,582.16
- P/E Ratio
- AVNW $243.80
- RCKT N/A
- Revenue Growth
- AVNW 6.50
- RCKT N/A
- 52 Week Low
- AVNW $12.96
- RCKT $2.19
- 52 Week High
- AVNW $26.83
- RCKT $18.17
- Technical
- Relative Strength Index (RSI)
- AVNW 57.73
- RCKT 58.98
- Support Level
- AVNW $22.71
- RCKT $3.67
- Resistance Level
- AVNW $25.32
- RCKT $4.06
- Average True Range (ATR)
- AVNW 0.90
- RCKT 0.28
- MACD
- AVNW 0.21
- RCKT 0.01
- Stochastic Oscillator
- AVNW 78.14
- RCKT 51.38
About AVNW Aviat Networks Inc.
Aviat Networks Inc is a networking solutions provider. It designs, manufactures and sells wireless networking products, solutions, and services to mobile and fixed operators, private network operators, government agencies, transportation and utility companies, public safety agencies, and broadcast network operators around the world. The company's product categories include point-to-point microwave and millimeter wave radios that are licensed (subject to local frequency regulatory requirements), lightly licensed and license-exempt (operating in license-exempt frequencies), and element and network management software.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.